PUBLIC CONTRACT · 2022
Aquisição de Octreotido 30 mg Pó susp. inj. Fr IM
- Contract value
- €1,639.75
- Signed on
- 23 November 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9738481PUBLISHED SUBJECT
Aquisição de Octreotido 30 mg Pó susp. inj. Fr IM
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Viana do Castelo, Viana do Castelo
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €1,639.75
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 26 January 2023
- Award date
- 23 November 2022
- Signing date
- 23 November 2022
- Performance period
- 38 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/47 - Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6295275
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.